Smartphone-based gait assessment of psychiatric patients on neuroleptics
Objective: To characterize gait performance recorded from psychiatric patients on neuroleptics (PPN) and to compare it to Parkinson’s disease (PD) patients and healthy controls (HC).…Fatigue in Parkinson’s disease and its relation with disease duration and treatment
Objective: Identify the presence of fatigue in a population of PD patients, establishing its association with disease duration and treatment. Background: Fatigue is one of…Auditory processing in young patients of Essential Tremor
Objective: The study aims at exploring auditory aspects in young patients with Essential Tremor. Background: Patients with Essential tremor (ET) manifest with motor as well…Glycopyrrolate as inhalation for treating sialorrhea in Parkinson’s Disease
Objective: To evaluate the safety, tolerability and effect of glycopyrrolate inhalations in PD patients with sialorrhea. Background: Sialorrhea is reported in up to 60 percent…Executive functions correlate with DaT-SPECT laterality in Parkinson’s disease
Objective: The aim of this study is to assess whether the impairment of executive functions is associated with the laterality of the affected nigro-striatal pathway…Clinical and neuroimaging heterogeneity of dementia with Lewy bodies
Objective: To study clinical and neuroimaging features of dementia with Lewy bodies (DLB) for optimal management and prognosis of the disease. Background: Appropriate diagnosis of DLB…Visuospatial dysfunction correlates with severity of postural instability/gait disturbance symptoms in parkinson’s disease
Objective: Investigate the relationship between global and specific cognitive functions and PIGD symptoms in Parkinson’s disease Background: It is well known that cognition and motor…Vascular risk factors, WMLs and the risk of cognitive impairment in Parkinson disease: A longitudinal study from the Parkinson’s Disease Cognitive Impairment Study (PaCoS) cohort
Objective: To identify modifiable vascular risk factors (VRFs) associated with cognitive decline in early PD. Background: The importance of the early identification of modifiable risk…Identifying subtypes of Mild Cognitive Impairment in Parkinson’s disease using cluster analysis
Objective: To identify cognitive phenotypes within Parkinson’s disease (PD) and compare them to the current Movement Disorder Society (MDS) diagnostic standards for Mild Cognitive Impairment…Heart Rate Variability and Cognitive Impairment in Parkinson’s Disease
Objective: To evaluate the association between the heart rate variability (HRV) and cognitive impairment in PD patients. Background: Emerging evidence suggests an association between cognitive…
- « Previous Page
- 1
- …
- 49
- 50
- 51
- 52
- 53
- …
- 217
- Next Page »
